Physician profile
Scott Frey
NPI 1144699380
$364,711.79
in general payments reported to CMS, 2019-2025
6 companies · $68K in 2025
The $68K reported for 2025 was more than what 99% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97K · 2020: $70K · 2021: $52K · 2022: $24K · 2023: $22K · 2024: $32K · 2025: $68K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $85K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $28K · Travel and Lodging: $7,417 · Food and Beverage: $1,270 · Gift: $86.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $84,980.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,775.00 |
| Travel and Lodging | $7,416.74 |
| Food and Beverage | $1,269.54 |
| Gift | $86.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $321,312.16 | 2019-2025 | Invisalign, Itero |
| Ortho Organizers, INC. | $43,228.77 | 2019-2021 | |
| Nobel Biocare USA | $46.16 | 2023 | Nobelactive |
| Ormco Corporation | $46.16 | 2023 | Spark |
| Biolase, INC. | $44.45 | 2019 | |
| 3m Company | $34.09 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Frey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.